Abstract
Introduction

42
The emergence of resistance to the antibiotics among the biofilm forming Pseudomonas 43 aeruginosa has become a great public health problem worldwide. Infection by P. aeruginosa is 44 complicated due to its various virulence factors, such as extracellular proteases, toxins and the 45 formation of biofilm (Neidig et al., 2013; Newman et al., 2017) . The emergence of antibiotic 46 resistance is believed to be due to the overuse of drugs that allows the bacteria to adapt and 47 modify the virulence factors (Winstanley et al., 2016) . The important mechanisms to resist 48 different classes of antibiotics are; mutations in target genes such as DNA gyrase and 49 topoisomerase IV; over-expression of efflux pumps; changes in the cell envelope; 50 downregulation of membrane porins (Kamath et al., 2016) , modified lipopolysaccharide 51 component of the outer cell membrane; production of beta-lactamase and aminoglycoside 52 modifying enzymes. Biofilm formation is another trait that offers benefit to the bacteria against 53 antibiotic stress and hence, the cells inside the biofilms are more resistant to antibiotics than the 54 planktonic cells (Melander, 2010; Olsen, 2015) . Because of this versatility of bacteria, the 55 existing antibiotic treatments are often ineffective against P. aeruginosa persistent infections.
56
Colistin, a polymyxin antibiotic is considered as the last resort therapy for multi-drug resistant 57 (MDR) P. aeruginosa, but due to its extreme cytotoxicity, its use is restricted. However, the 58 emergence of colistin resistant strains are reported from various parts of the world warranting 59 serious measures (Nation and Li, 2009; Srinivas and Rivard, 2017 there were residual cells in the biofilm, the biofilm viability was tested by adding fresh TSB to 131 allow the growth of residual cells for 24 h at 37 °C. After incubation, the growth was measured
132
at OD 600 and compared with the growth in the non-treated control wells to calculate the percent 133 cell viability in the biofilm. Further, the samples from each well were serially diluted and plated 134 on tryptic soy agar plates to confirm the cell viability (Nair et al., 2016) .
135
Live/dead assay for the biofilm
136
The live/dead staining was used to study the biofilm viability after treating with the quercetin biofilm acquired were processed using Zen 2011 software (Carl Zeiss) (Bédard et al., 2014) .
148
Statistical analysis 149
The experiments are performed thrice in triplicates. The statistical analysis was performed by 150 student's test using SPSS version 22 (SPSS Inc., Chicago, IL, USA). P values of <0.05 were 151 regarded as significant.
Minimum inhibitory concentrations
154
The MIC of the antibiotics against YU-V10, YU-V28 and PAO1 is given in Table. 1. The MIC 155 for levofloxacin ranged between 2 and 8 µg/mL, tobramycin it was between 3 and 6 µg/mL.
156
Interaction of quercetin with antibiotics 157
In combination with quercetin, the antibiotics showed 2 to 4-fold decrease in the MICs. The quercetin and all the tested antibiotics against P. aeruginosa isolates are given in Table. 2.
167
Effect of drug combinations on growth and biofilm viability 168
In the time kill assay, the effect of drug combinations on bacteria in the early stage of growth
169
showed a significant reduction in the bacterial growth compared to control. (Fig. 2a-b) .
174
The efficacy of drug combinations on the viability of a fully formed biofilm community 175 is given in fig 3 and viability in PAO1 in quercetin-amikacin and quercetin-tobramycin combinations (Fig. 3a-b) .
179
The live/dead assay also confirmed the decrease in the viable cells in the biofilm matrix with in the biofilm matrix (Fig. 4) .
184
Discussion
185
This study showed that the quercetin in combination with antibiotics can increase the antibiotics is a promising strategy to combat antibiotic resistance and biofilms associated P. 
